Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site




VERTEX PHARMACEUTICALS INCORPORATED (VRTX)

The QuantWave forecast for VRTX vertex pharmaceuticals incorporated

Vertex Pharmaceuticals Incorporated is a biotechnology company that specializes in the discovery, development, and commercialization of innovative medicines for the treatment of serious diseases. With its headquarters in Boston, Massachusetts, the company has established itself as a leader in the field of precision medicine, utilizing advanced scientific techniques to target specific genetic mutations underlying various disorders. Vertex is known for its groundbreaking therapies for cystic fibrosis, a life-threatening genetic disease affecting the lungs and digestive system. The company's research and development efforts also extend to other progressive diseases, such as alpha-1 antitrypsin deficiency and sickle cell disease. With a strong focus on collaboration and strategic partnerships, Vertex continually pushes the boundaries of scientific knowledge to deliver life-changing treatments to patients in need.
The graph shows the results of our forecasting system for VRTX. You can view historical price data with some markers indicating where our system has been signaling and where the projected targets have been achieved. This demonstrates to what extent our system's forecasts have been justified in real market conditions.

We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page

Access the VRTX Forecast by QuantWave

Stock ticker: VRTX
Name: VERTEX PHARMACEUTICALS INCORPORATED
Sector: Healthcare
Investing Risk: MEDIUM
Forecast length: 7 days
Accuracy: 36.81 %
Average profit per target: 5.49 %


VRTX Achieves Targets with Precision, as Predicted by QuantWave

Show news about the achieved forecast
Signal Date Signal Price Date Reached Price Reached Profit Direction
2022-06-07271.86 $2022-08-09298.83 $ 9.92%
2024-02-27430.92 $2024-07-10491.62 $ 14.09%
2024-03-05415.44 $2024-06-04474.95 $ 14.32%
2024-03-12412.45 $2024-07-10491.62 $ 19.2%
2024-05-14428.59 $2024-07-30502.6 $ 17.27%
2024-10-01469.76 $2024-12-19396.64 $ 15.57%
2024-10-08458.94 $2024-12-19396.64 $ 13.57%
2024-10-15484.3 $2024-12-19396.64 $ 18.1%
2024-10-22474.91 $2024-12-19396.64 $ 16.48%
2024-12-13463.73 $2025-03-17513.76 $ 10.79%
2024-12-17469.24 $2025-03-17513.76 $ 9.49%

Access the VRTX Forecast by QuantWave


The latest news about the achievement of forecasting results and global news about vertex pharmaceuticals incorporated


VRTXJune 8, 2025Vertex Pharmaceuticals Incorporated VRTX Reports Positive Outcomes from CFTR Modulator Studies  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) recently announced positive outcomes from their CFTR modulator studies, showing promising results in the treatment of cystic fibrosis....

VRTXMay 31, 2025Vertex Pharmaceuticals Incorporated Continues to Impress Investors With Groundbreaking Research  ~1 min.

Vertex Pharmaceuticals Incorporated has been making waves in the pharmaceutical industry with its innovative research and development efforts....

VRTXMay 12, 2025Vertex Pharmaceuticals Incorporated VRTX Surged On a Recovery in Investor Sentiment  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) experienced a surge in its stock price due to a recovery in investor sentiment....

VRTXMay 10, 2025VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) saw its stock dip after the first quarter earnings report fell short of expectations for sales of new drugs....

VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....

VRTXMarch 19, 2025Investing in Vertex Pharmaceuticals: A Lucrative Opportunity for Biotech Enthusiasts  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has emerged as one of the most promising biotech stocks in the market, attracting the attention of top investors....

VRTXMarch 18, 2025Why Vertex Pharmaceuticals Incorporated VRTX is the Best Pharma Stock to Buy According to Hedge Funds  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been gaining attention from hedge funds as the best pharma stock to buy, and here's why....

VRTXMarch 17, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Price Target with a Profit of 9.49%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the forecast price target set by QuantWave on December 17, 2024. The forecast signal indicated a "long" direction with a price of $469....

VRTXMarch 17, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits 10.79% Profit Target as Predicted by QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has achieved the price target forecast set by QuantWave, resulting in a profit of 10.79%. The forecast signal was given on December 13, 2024, with a price of 463....

VRTXMarch 16, 2025Vertex Pharmaceuticals VRTX: A Pharma Success Story  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been making waves in the pharmaceutical industry, consistently outperforming the broader market....




Other QuantWave offers: